Doctor Now
PrivateLast Round
Series C
Apr 18, 2025
Est. Valuation
$156.6M
Total Funding Raised
$39.78M
Company Overview
Doctor Now is a telemedicine and healthcare technology company that provides remote medical consultations and prescription drug delivery services, allowing customers in Korea to manage their health conveniently and efficiently.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Mobile Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doctor Now Comps
Public and private peers based on sector, stage, and business model.
Doctor Now Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 18, 2025 | ||||
| Series B | Jun 2, 2022 | ||||
| Series A | Oct 13, 2021 |
Key People
Founding team and executive leadership
Doctor Now Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Goodwater Capital | Series B |
| Spring Ventures | Series B |
| Hashed | Series A, Series B |
| Mirae Asset Capital | Series B |
| CRIT Ventures | Series A, Series B |
Doctor Now Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Doctor Now's valuation, stock price, and market status.
